Mitochondria-targeted esculetin inhibits PAI-1 levels by modulating STAT3 activation and miR-19b via SIRT3: Role in acute coronary artery syndrome
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mitochondria-targeted esculetin inhibits PAI-1 levels by modulating STAT3 activation and miR-19b via SIRT3: Role in acute coronary artery syndrome
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 233, Issue 1, Pages 214-225
Publisher
Wiley
Online
2017-02-18
DOI
10.1002/jcp.25865
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- STAT3-regulated exosomal miR-21 promotes angiogenesis and is involved in neoplastic processes of transformed human bronchial epithelial cells
- (2016) Yi Liu et al. CANCER LETTERS
- Mitochondria-targeted esculetin alleviates mitochondrial dysfunction by AMPK-mediated nitric oxide and SIRT3 regulation in endothelial cells: potential implications in atherosclerosis
- (2016) Santosh Karnewar et al. Scientific Reports
- MicroRNA-19b/221/222 induces endothelial cell dysfunction via suppression of PGC-1α in the progression of atherosclerosis
- (2015) Yunxing Xue et al. ATHEROSCLEROSIS
- Esculetin attenuates alterations in Ang II and acetylcholine mediated vascular reactivity associated with hyperinsulinemia and hyperglycemia
- (2015) Almesh Kadakol et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- ThemiR-19a/bfamily positively regulates cardiomyocyte hypertrophy by targeting atrogin-1 and MuRF-1
- (2013) Dong Woo Song et al. BIOCHEMICAL JOURNAL
- SIRT3 deacetylates FOXO3 to protect mitochondria against oxidative damage
- (2013) Anne H.H. Tseng et al. FREE RADICAL BIOLOGY AND MEDICINE
- Let-7g Improves Multiple Endothelial Functions Through Targeting Transforming Growth Factor-Beta and SIRT-1 Signaling
- (2013) Yi-Chu Liao et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- DNA Damage Induces NF-κB-dependent MicroRNA-21 Up-regulation and Promotes Breast Cancer Cell Invasion
- (2012) Jixiao Niu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SIRT3 Protein Deacetylates Isocitrate Dehydrogenase 2 (IDH2) and Regulates Mitochondrial Redox Status
- (2012) Wei Yu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Circulating MicroRNAs
- (2011) Stephan Fichtlscherer et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Involvement ofmiR-30candmiR-301ain immediate induction of plasminogen activator inhibitor-1 by placental growth factor in human pulmonary endothelial cells
- (2011) Nitin Patel et al. BIOCHEMICAL JOURNAL
- Biogenesis and Regulation of Cardiovascular MicroRNAs
- (2011) Johann Bauersachs et al. CIRCULATION RESEARCH
- Apelin protects against angiotensin II-induced cardiovascular fibrosis and decreases plasminogen activator inhibitor type-1 production
- (2011) Khandaker Siddiquee et al. JOURNAL OF HYPERTENSION
- MicroRNAs in Arterial Remodelling, Inflammation and Atherosclerosis
- (2010) C. Weber et al. CURRENT DRUG TARGETS
- The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients
- (2010) Edward J. Gane et al. LIVER INTERNATIONAL
- Protective effect of esculetin against oxidative stress-induced cell damage via scavenging reactive oxygen species
- (2009) So-hyung Kim et al. ACTA PHARMACOLOGICA SINICA
- Mitochondria-Targeted Antioxidant MitoQ 10 Improves Endothelial Function and Attenuates Cardiac Hypertrophy
- (2009) Delyth Graham et al. HYPERTENSION
- Control of protein synthesis and mRNA degradation by microRNAs
- (2008) Jidong Liu CURRENT OPINION IN CELL BIOLOGY
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started